| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
11,762 |
9,435 |
$347K |
| 94729 |
|
7,604 |
6,490 |
$202K |
| 94726 |
|
6,763 |
5,838 |
$163K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,497 |
2,908 |
$157K |
| 94010 |
|
7,005 |
5,962 |
$88K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
749 |
639 |
$55K |
| 94618 |
|
958 |
836 |
$16K |
| 94060 |
|
507 |
449 |
$15K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
611 |
488 |
$6K |
| 94644 |
|
207 |
167 |
$5K |
| 94727 |
|
458 |
353 |
$5K |
| 94728 |
|
298 |
252 |
$2K |
| 94070 |
|
27 |
26 |
$1K |
| 95070 |
|
27 |
26 |
$568.73 |
| J7674 |
Methacholine chloride administered as inhalation solution through a nebulizer, per 1 mg |
28 |
27 |
$379.84 |
| J7611 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg |
142 |
123 |
$21.96 |
| J7644 |
Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram |
93 |
75 |
$8.94 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
14 |
12 |
$0.51 |
| J7633 |
Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, per 0.25 milligram |
71 |
56 |
$0.28 |
| G8484 |
Influenza immunization was not administered, reason not given |
5,975 |
5,045 |
$0.00 |